ISPECIMEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.266 USD | -5.07% |
|
-7.73% | -46.86% |
| Mar. 26 | ISpecimen Inc. Announces the Board Changes | CI |
| Mar. 14 | Transcript : ISpecimen Inc., 2023 Earnings Call, Mar 14, 2024 |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 68.07 | 12.26 | 4.543 | 2.485 | - | - |
| Enterprise Value (EV) 1 | 68.07 | 12.26 | 4.543 | 2.485 | 2.485 | 2.485 |
| P/E ratio | -3.74 x | -1.19 x | -0.41 x | -0.23 x | -0.23 x | - |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 6.11 x | 1.18 x | 0.46 x | 0.22 x | 0.2 x | 0.17 x |
| EV / Revenue | 6.11 x | 1.18 x | 0.46 x | 0.22 x | 0.2 x | 0.17 x |
| EV / EBITDA | -13.8 x | -1.37 x | -0.5 x | -0.26 x | -0.24 x | - |
| EV / FCF | -5.85 x | -1.36 x | -0.43 x | -0.17 x | -0.16 x | -0.23 x |
| FCF Yield | -17.1% | -73.5% | -232% | -589% | -615% | -430% |
| Price to Book | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 8,716 | 8,918 | 9,076 | 9,344 | - | - |
| Reference price 2 | 7.810 | 1.375 | 0.5006 | 0.2660 | 0.2660 | 0.2660 |
| Announcement Date | 2/17/22 | 3/14/23 | 3/13/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 11.14 | 10.4 | 9.928 | 11.54 | 12.7 | 14.61 |
| EBITDA 1 | - | -4.921 | -8.981 | -9.054 | -9.457 | -10.15 | - |
| EBIT 1 | - | -5.925 | -10.19 | -11.17 | -12.08 | -13.58 | -9.494 |
| Operating Margin | - | -53.21% | -97.92% | -112.5% | -104.72% | -106.89% | -65% |
| Earnings before Tax (EBT) 1 | - | -8.962 | -10.25 | -11.1 | -11.96 | -13.54 | - |
| Net income 1 | -4.652 | -8.962 | -10.25 | -11.1 | -11.96 | -13.54 | - |
| Net margin | - | -80.48% | -98.5% | -111.8% | -103.67% | -106.57% | - |
| EPS 2 | -4.970 | -2.090 | -1.160 | -1.230 | -1.150 | -1.150 | - |
| Free Cash Flow 1 | - | -11.63 | -9.009 | -10.55 | -14.64 | -15.29 | -10.68 |
| FCF margin | - | -104.44% | -86.6% | -106.28% | -126.92% | -120.42% | -73.13% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 4/2/21 | 2/17/22 | 3/14/23 | 3/13/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2.549 | 2.519 | 2.339 | 2.583 | 2.962 | 2.95 | 1.625 | 2.778 | 2.575 | 2.844 | 2.881 | 2.892 | 2.92 |
| EBITDA 1 | -1.739 | -1.891 | -2.064 | -2.173 | -1.776 | -2.071 | -3.023 | -1.67 | -2.291 | -2.286 | -2.264 | -2.378 | -2.529 |
| EBIT 1 | -1.995 | -2.358 | -2.585 | -3.101 | -2.142 | -2.542 | -3.562 | -2.194 | -2.871 | -2.867 | -2.895 | -3.059 | -3.26 |
| Operating Margin | -78.26% | -93.64% | -110.53% | -120.04% | -72.31% | -86.18% | -219.17% | -78.99% | -111.49% | -100.81% | -100.49% | -105.77% | -111.64% |
| Earnings before Tax (EBT) 1 | -2.05 | -2.384 | -2.607 | -3.096 | -2.16 | -2.432 | -3.484 | -2.111 | -3.073 | -2.83 | -2.862 | -3.032 | -3.237 |
| Net income 1 | -2.05 | -2.384 | -2.607 | -3.096 | -2.16 | -2.432 | -3.484 | -2.111 | -3.073 | -2.83 | -2.862 | -3.032 | -3.237 |
| Net margin | -80.44% | -94.64% | -111.46% | -119.83% | -72.92% | -82.43% | -214.36% | -76% | -119.33% | -99.51% | -99.34% | -104.84% | -110.86% |
| EPS 2 | -0.2700 | -0.2700 | -0.3000 | -0.3500 | -0.2400 | -0.2700 | -0.3900 | -0.2300 | -0.3400 | -0.2700 | -0.2800 | -0.2900 | -0.3100 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/17/22 | 5/10/22 | 8/4/22 | 11/8/22 | 3/14/23 | 5/4/23 | 8/2/23 | 11/2/23 | 3/13/24 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -11.6 | -9.01 | -10.6 | -14.6 | -15.3 | -10.7 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex 1 | - | 1.04 | 3.19 | 4.74 | 5.03 | 5.03 | 5.28 |
| Capex / Sales | - | 9.32% | 30.68% | 47.79% | 43.56% | 39.56% | 36.12% |
| Announcement Date | 4/2/21 | 2/17/22 | 3/14/23 | 3/13/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.266
USD
Average target price
3
USD
Spread / Average Target
+1,027.82%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -46.86% | 2.49M | |
| +5.58% | 82.93B | |
| +3.69% | 76.85B | |
| -14.62% | 53.04B | |
| -24.56% | 46.55B | |
| +31.16% | 50.15B | |
| +17.75% | 41.41B | |
| +55.21% | 35.63B | |
| -10.24% | 24.64B | |
| -21.24% | 23.04B |
- Stock Market
- Equities
- ISPC Stock
- Financials iSpecimen Inc.
